Page 6 - Alpha Da News Today

HC Wainwright began coverage on shares of Alpha Tau Medical (NASDAQ:DRTS – Get Rating) in a research report released on Monday, MarketBeat reports. The firm issued a buy rating and a $9.00 target price on the stock. HC Wainwright also issued estimates for Alpha Tau Medical’s Q1 2023 earnings at ($0.05) EPS, Q2 2023 earnings […]

HC Wainwright assumed coverage on shares of Alpha Tau Medical (NASDAQ:DRTS – Get Rating) in a report released on Monday, MarketBeat reports. The brokerage issued a buy rating and a $9.00 price target on the stock. HC Wainwright also issued estimates for Alpha Tau Medical’s Q1 2023 earnings at ($0.05) EPS, Q2 2023 earnings at […]

First patient treated in the feasibility and safety study of intratumoral diffusing alpha radiation emitters for the treatment of advanced inoperable pancreatic cancer. JERUSALEM, April 03,... | April 3, 2023

First patient treated in the feasibility and safety study of intratumoral diffusing alpha radiation emitters for the treatment of advanced inoperable...

Alpha Tau Medical (NASDAQ:DRTS – Get Rating) is one of 229 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it contrast to its peers? We will compare Alpha Tau Medical to related businesses based on the strength of its profitability, institutional ownership, valuation, analyst recommendations, risk, dividends and earnings. Analyst Ratings […]

Alpha Tau Medical (NASDAQ:DRTS – Get Rating) is one of 229 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it compare to its rivals? We will compare Alpha Tau Medical to related businesses based on the strength of its profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk. Volatility and […]

Radiation is commonly employed in hospitals around the world to treat tumors, typically using gamma ray beams of high energy photons, with a relatively

From the blog of Lili Eylon at The Times of Israel

JERUSALEM, Feb. 21, 2023 -- Alpha Tau Medical Ltd. , the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that the Company plans to participate in... | February 21, 2023

(2022-11-22 | NDAQ:DRTS) Alpha Tau Medical Announces Third Quarter 2022 Financial Results and Provides Corporate Update